Literature DB >> 16835248

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.

Steve Vucic1, Matthew C Kiernan.   

Abstract

The dying forward hypothesis of motor neuron disease (MND) suggests that corticomotoneurons induce excitotoxic anterior horn cell death, with involvement of the glutamatergic neurotransmitter system. The aim of the present study was to apply novel threshold tracking transcranial magnetic stimulation (TMS) techniques in conjunction with peripheral nerve excitability studies in MND patients to further investigate the dying forward hypothesis and possibly determine the site of disease onset. Studies were undertaken in 23 MND patients using a 90-mm circular coil connected to a BiStim magnetic stimulator for cortical studies and electrical stimulation for peripheral nerve excitability studies. Motor-evoked potentials and compound muscle action potentials (CMAPs) were recorded from the right abductor pollicis brevis in the same setting. Measures of cortical and peripheral nerve excitability were correlated with clinical and neurophysiological parameters of disease severity. Short-interval intracortical inhibition (SICI) was significantly reduced in MND patients compared with controls (MND group = 3.6 +/- 0.8%; controls = 8.5 +/- 1.0%, P < 0.001), most prominently in MND patients with limb-onset disease. Changes in intracortical inhibition were accompanied by alterations in the magnetic stimulus-response curve, cortical silent period duration and resting motor threshold, all indicative of cortical hyperexcitability. Although the reduction in SICI was more pronounced in MND patients with less severe disease, as assessed by the CMAP amplitude, it remained evident even in MND patients with advanced disease. Measures of peripheral disease burden, namely the CMAP amplitude (r = -0.6) and neurophysiological index (r = -0.6), correlated with cortical hyperexcitability changes, as did the strength-duration time constant (r = -0.6), a peripheral marker of axonal excitability. Simultaneous assessment of central and peripheral nerve excitability has established the presence of co-existent upper and lower motor neuron dysfunction, with cortical hyperexcitability an early feature in MND.

Entities:  

Mesh:

Year:  2006        PMID: 16835248     DOI: 10.1093/brain/awl172

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  90 in total

Review 1.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

2.  Physiology of the fasciculation potentials in amyotrophic lateral sclerosis: which motor units fasciculate?

Authors:  Mamede de Carvalho; Michael Swash
Journal:  J Physiol Sci       Date:  2016-09-16       Impact factor: 2.781

3.  Superconditioning TMS for examining upper motor neuron function in MND.

Authors:  Blair Calancie; Eufrosina Young; Mary Lou Watson; Dongliang Wang; Natalia Alexeeva
Journal:  Exp Brain Res       Date:  2019-06-07       Impact factor: 1.972

Review 4.  Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to Therapy.

Authors:  Dzung Do-Ha; Yossi Buskila; Lezanne Ooi
Journal:  Mol Neurobiol       Date:  2017-02-03       Impact factor: 5.590

5.  Chronic electromyograms in treadmill running SOD1 mice reveal early changes in muscle activation.

Authors:  Katharina A Quinlan; Elma Kajtaz; Jody D Ciolino; Rebecca D Imhoff-Manuel; Matthew C Tresch; Charles J Heckman; Vicki M Tysseling
Journal:  J Physiol       Date:  2017-07-05       Impact factor: 5.182

Review 6.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 7.  Clinical diagnosis and management of amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Leonard H van den Berg; Matthew C Kiernan
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

8.  Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-08       Impact factor: 10.154

Review 9.  Neurophysiological markers of network dysfunction in neurodegenerative diseases.

Authors:  Roisin McMackin; Peter Bede; Niall Pender; Orla Hardiman; Bahman Nasseroleslami
Journal:  Neuroimage Clin       Date:  2019-02-02       Impact factor: 4.881

10.  Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia.

Authors:  Steve Vucic; Benjamin C Cheah; Con Yiannikas; Angela Vincent; Matthew C Kiernan
Journal:  Brain       Date:  2010-08-23       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.